An Improved System to Evaluate Superoxide‐Scavenging Effects of Bioflavonoids

por Yao, Yuanyong, Chen, Shixue, Li, Hu
Publicado 2021

Sustainable Approaches to Selective Conversion of Cellulose Into 5-Hydroxymethylfurfural Promoted by Heterogeneous Acid Catalysts: A Review

por Yao, Yuanyong, Chen, Shixue, Zhang, Meng
Publicado 2022

Evaluation of General Synthesis Procedures for Bioflavonoid–Metal Complexes in Air-Saturated Alkaline Solutions

por Yao, Yuanyong, Zhang, Meng, He, Laibing, Wang, Yunyang, Chen, Shixue
Publicado 2020

Corrigendum: Evaluation of General Synthesis Procedures for Bioflavonoid–Metal Complexes in Air-Saturated Alkaline Solutions

por Yao, Yuanyong, Zhang, Meng, He, Laibing, Wang, Yunyang, Chen, Shixue
Publicado 2020

Immunoglobulin Gamma-Like Therapeutic Bispecific Antibody Formats for Tumor Therapy

por Chen, Shixue, Li, Lingling, Zhang, Fan, Wang, Yu, Hu, Yi, Zhao, Lei
Publicado 2019

Association of Helicobacter pylori infection with survival outcomes in advanced gastric cancer patients treated with immune checkpoint inhibitors

por Che, Hebin, Xiong, Qi, Ma, Jinxia, Chen, Shixue, Wu, Huan, Xu, Hongli, Hou, Baicun
Publicado 2022

Nab-Paclitaxel in combination with Cisplatin Versus Docetaxel Plus Cisplatin as First-Line Therapy in Non-small Cell Lung Cancer

por Chen, Yi, Li, Jinyu, Chen, Shixue, Zhang, Yibao, Hu, Yi, Zhang, Guoqing, Yan, Xiang, Jiao, Shunchang
Publicado 2017

Association of immune-related pneumonitis with the efficacy of PD-1/PD-L1 inhibitors in non-small cell lung cancer

por Cui, Pengfei, Huang, Di, Wu, Zhaozhen, Tao, Haitao, Zhang, Sujie, Ma, Junxun, Liu, Zhefeng, Wang, Jinliang, Huang, Ziwei, Chen, Shixue, Zheng, Xuan, Hu, Yi
Publicado 2020

The Synergistic Effect of PARP Inhibitors and Immune Checkpoint Inhibitors

por Wu, Zhaozhen, Cui, Pengfei, Tao, Haitao, Zhang, Sujie, Ma, Junxun, Liu, Zhefeng, Wang, Jinliang, Qian, Yuanyu, Chen, Shixue, Huang, Ziwei, Zheng, Xuan, Huang, Di, Hu, Yi
Publicado 2021

Response Efficacy of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-Analysis

por Chen, Shixue, Zhang, Zhibo, Zheng, Xuan, Tao, Haitao, Zhang, Sujie, Ma, Junxun, Liu, Zhefeng, Wang, Jinliang, Qian, Yuanyu, Cui, Pengfei, Huang, Di, Huang, Ziwei, Wu, Zhaozhen, Hu, Yi
Publicado 2021

Efficacy and safety of anti-PD-1-based therapy in combination with PARP inhibitors for patients with advanced solid tumors in a real-world setting

por Wu, Zhaozhen, Tao, Haitao, Zhang, Sujie, Wang, Xiao, Ma, Junxun, Li, Ruixin, Liu, Zhefeng, Wang, Jinliang, Cui, Pengfei, Chen, Shixue, Di, Huang, Huang, Ziwei, Zheng, Xuan, Hu, Yi
Publicado 2021

Association of the Pretreatment Lung Immune Prognostic Index with Survival Outcomes in Advanced Hepatocellular Carcinoma Patients Treated with PD-1 Inhibitors

por Chen, Shixue, Huang, Ziwei, Jia, Wangping, Tao, Haitao, Zhang, Sujie, Ma, Junxun, Liu, Zhefeng, Wang, Jinliang, Wang, Lijie, Cui, Pengfei, Zhang, Zhibo, Huang, Di, Wu, Zhaozhen, Zheng, Xuan, Hu, Yi
Publicado 2020

Prognostic value of baseline and change in neutrophil-to-lymphocyte ratio for survival in advanced non-small cell lung cancer patients with poor performance status receiving PD-1 i...

por Chen, Shixue, Li, Ruixin, Zhang, Zhibo, Huang, Ziwei, Cui, Pengfei, Jia, Wangping, Zhang, Sujie, Tao, Haitao, Wang, Lijie, Li, Xiaoyan, Wang, Jinliang, Ma, Junxun, Liu, Zhefeng, Huang, Di, Zheng, Xuan, Saito, Yuichi, Ichiki, Yoshinobu, Hu, Yi
Publicado 2021

Anti-PD-1 therapy combined with chemotherapy in patients with advanced biliary tract cancer

por Sun, Danyang, Ma, Junxun, Wang, Jinliang, Han, Chun, Qian, Yuanyu, Chen, Guangying, Li, Xiaoyan, Zhang, Juan, Cui, Pengfei, Du, Wushuang, Wu, Zhaozhen, Chen, Shixue, Zheng, Xuan, Yue, Zhichao, Song, Jia, Gao, Chan, Zhao, Xiaochen, Cai, Shangli, Hu, Yi
Publicado 2019